In this scenario, a prospective cohort including 278 patients with completely resected stage IA-IIIA EGFR-mutant NSCLC explored the longitudinal ctDNA status by digital-droplet polymerase chain reaction. Here, EGFR is linked to non-small cell lung carcinoma.